{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-076313","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.876404+00:00","generated_at":"2026-06-01T00:33:48.549025+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"DarioHealth amends Series B and B-1 Preferred Stock, extends conversion period, adds dividends","bullets":["Mandatory conversion period extended from 15 to 18 months from original issue date.","Series B and B-1 holders get 10% dividend for fifth full quarter, 25% for sixth quarter from closing.","No additional securities were issued or sold as a result of the amendment.","Amendments filed on June 25, 2024, effective upon filing with Delaware Secretary of State."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-076313","json":"https://secwatch.observer/filing/0001104659-24-076313.json","markdown":"https://secwatch.observer/filing/0001104659-24-076313.md","text":"https://secwatch.observer/filing/0001104659-24-076313.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924076313/0001104659-24-076313-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465924076313/tm2418444d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:33:48.549025+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}